Yeast: toasting the end

Yeast research as we know it will end with the solving of the organism on April 1, 2007, give or take 8.37 days. So said Mark Johnston, president of the Genetics Society of America, presenting on the future of the model organism at the biannual Yeast Genetics and Molecular Biology meeting this past month in Seattle. In combing through the Yeast Proteome Database, he found that so-called known yeast genes have followed a remarkably linear upward trajectory, reaching 4,679 as of the end of July of

Written byBrendan Maher
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Yeast research as we know it will end with the solving of the organism on April 1, 2007, give or take 8.37 days. So said Mark Johnston, president of the Genetics Society of America, presenting on the future of the model organism at the biannual Yeast Genetics and Molecular Biology meeting this past month in Seattle. In combing through the Yeast Proteome Database, he found that so-called known yeast genes have followed a remarkably linear upward trajectory, reaching 4,679 as of the end of July of this year. A continuation of that trend, says Johnston, of Washington University in St. Louis, will mean that the organism's 6,000 genes will be known by April Fool's Day 2007.

The prediction has inherent flaws and implied cheek. Budding grad students need not fear; even a 'known' gene can still be pretty mysterious. The University of Toronto's Tim Hughes put things into perspective; he ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies